Net revenues (Tables)

3 Months Ended

Mar. 27, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments

The following table disaggregates revenue by global product category for the three months ended March 27, 2022 and March 28, 2021.

	Three Months Ended
	March 27, 2022		March 28, 2021
Vascular access	$	166,134	$	163,973
Anesthesia	86,957		84,857
Interventional	96,859		96,173
Surgical	89,702		80,386
Interventional urology	74,895		73,364
OEM	57,656		53,489
Other (1)	69,512		81,683
Net revenues (2)	$	641,715	$	633,925

(1)Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products). Certain product lines within the respiratory product category were sold during 2021. See Note 4 for additional information related to the Respiratory business divestiture

(2)The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments include net revenues from each of the non-OEM product categories listed above.